In a recent development, CDT Equity Inc., a company operating within the Health Care sector and listed on the Nasdaq, has announced a significant change in its independent registered public accounting firm. This change, detailed in a current report filed on June 29, 2026, marks a pivotal moment for the company as it transitions from CBIZ CPAs P.C. to Carr, Riggs & Ingram L.L.C. The decision, approved by the audit committee, reflects the company’s ongoing efforts to strengthen its financial oversight and reporting mechanisms.
CDT Equity Inc., with a market capitalization of approximately $3,089,910 USD, has experienced notable fluctuations in its stock price over the past year. The company’s close price on June 28, 2026, stood at $0.583, a stark contrast to its 52-week high of $586 on July 2, 2025. This volatility underscores the challenges faced by the company, particularly in light of the substantial doubt about its ability to continue as a going concern, as noted in the prior auditor’s statements for the year ended December 31, 2025.
Despite these challenges, the transition to a new accounting firm was executed without any recorded disagreements with CBIZ CPAs P.C. during their tenure from April 2025 until the change in June 2026. Furthermore, no additional reportable events were identified beyond the previously disclosed material weaknesses in internal controls. This smooth transition is indicative of the company’s commitment to maintaining transparency and accountability in its financial reporting.
As an emerging growth company, CDT Equity Inc. continues to navigate the complexities of the health care sector. The company’s focus on clinical assets from pharmaceutical companies that have been deprioritized aligns with its mission to accelerate the development of new treatments for patients. This strategic approach positions CDT Equity Inc. to potentially capitalize on opportunities within the life sciences industry, despite the financial uncertainties it currently faces.
The company’s recent filing includes the usual financial statements and exhibits, ensuring that stakeholders are well-informed about its financial position and strategic direction. As CDT Equity Inc. moves forward with Carr, Riggs & Ingram L.L.C. as its new independent registered public accounting firm, it remains committed to addressing the challenges highlighted in previous reports and strengthening its internal controls.
In summary, the change in accounting firms for CDT Equity Inc. represents a critical step in the company’s ongoing efforts to enhance its financial oversight and address the substantial doubts about its future viability. As the company continues to operate as a Nasdaq-listed emerging growth entity, its focus on innovative clinical assets and new treatment development remains a cornerstone of its strategic vision.
